SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001079973-24-000604
Filing Date
2024-04-29
Accepted
2024-04-29 08:10:10
Documents
16
Period of Report
2024-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K scpx_8k.htm   iXBRL 8-K 28440
2 EXHIBIT 99.1 ex99x1.htm EX-99.1 13669
3 GRAPHIC image_001.jpg GRAPHIC 10182
  Complete submission text file 0001079973-24-000604.txt   278111

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE scpx-20240429.xsd EX-101.SCH 3549
5 XBRL DEFINITION FILE scpx-20240429_def.xml EX-101.DEF 26579
6 XBRL LABEL FILE scpx-20240429_lab.xml EX-101.LAB 36527
7 XBRL PRESENTATION FILE scpx-20240429_pre.xml EX-101.PRE 25203
19 EXTRACTED XBRL INSTANCE DOCUMENT scpx_8k_htm.xml XML 5514
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
Scorpius Holdings, Inc. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 24886689
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)